Bioniq Health-Tech Solutions Limited

Bioniq Health-Tech Solutions Ltd, based in the UK, specializes in health and wellness technologies, focusing on personalized nutritional products that enhance individual health through tailored micronutrient blends. Bioniq Health-Tech Solutions Ltd was founded in 2019 and is headquartered in London, UK. The company provides innovative health solutions, pivoting towards personalized nutritional offerings. The founders, Calin Popescu, Constantin Karuzin, and Vadim Fedotov, have a history of entrepreneurship, with Vadim Fedotov currently serving as CEO.

Bioniq has successfully completed 4 deals, with their most recent funding round occurring in March 2025, raising EUR 1 million. Bioniq specializes in advanced health and wellness solutions, focusing primarily on personalized nutritional products and supplements. Their core offerings include tailored micronutrient blends designed to optimize individual health based on specific needs and lifestyles. The company employs a unique approach that combines scientific research with bio-individuality, allowing customers to receive products that address unique health challenges such as energy levels, immune support, and overall well-being.

Bioniq's products are primarily aimed at health-conscious consumers, wellness enthusiasts, and individuals seeking preventive health measures. The company has successfully penetrated markets in Europe, North America, and Asia, catering to a diverse client base that includes both individual consumers and health practitioners. Bioniq generates revenue through a direct-to-consumer model, where customers purchase personalized supplement subscriptions tailored to their health needs. This subscription model allows users to receive regular shipments of their customized products, fostering long-term customer relationships and consistent revenue streams.

The company's pricing strategy includes various tiers based on the complexity of the personalized service, ensuring accessibility for a wide range of consumers. Flagship products, which are often highlighted for their unique formulations, play a significant role in driving sales. Overall, Bioniq's transactional structure, built around personalized offerings, positions the company to effectively serve its clientele while maximizing revenue potential through repeat purchases. In March 2025, Bioniq Health-Tech Solutions Limited raised EUR 1 million in venture funding from an individual investor.

The company plans to utilize this funding to expand operations and increase its business reach. Future initiatives include the development of new tailored health products and expanding into additional markets across Europe and Asia by late 2025.